Matching Pairs Diabetes Oral MedsOnline version NUr115 Oral Diabetic Agents by Concetta Fiorentino 1 Inhibit production of glucose by the liver. 2 Usually given once a day. 3 Drug to drug interaction with NSAIDS. 4 Prevents kidneys from reabsorbing glucose. 5 Possible side-effect of impaired platelet function. 6 Stimulate beta cells of the pancreas. 7 Enhances glucose-dependent insulin secretion. 8 Stimulate pancreas to secrete insulin. 9 Do not increased insulin secretion. 10 Sensitize body tissue to insulin: stimulates insulin receptor sites. 11 Increase and prolong the action of the hormone that increases insulin release and decreases glucagon levels. Sodium-glucose co-transporter 2 inhibitors (empagliflozin/Jardiance glipizide Avandia Alpha-glucosidase inhibitors (acarbose/Precose, miglitol (Glyset) Thiazolidinediones (pioglitazone (actos, rosiglitazone/Avandia) Glucagon-like peptide-1 agonist (liraglutide/Victoza,, dulaglutide/Trulicity) Non-sulfonylurea insulin secretagogues (repaglinide/Prandin, nateglinide/Starlix) Dipeptidyl Pepidase-4 Inhibitors (sitagliptin/Januvia, vildagliptin /Galvus) Second generation sulfonylureas (glipizide (Glucotrol) Glyburide (DiaBeta) Glimepiride (Amaryl) Januvia Biguanides (metformin (Glucophage) Metformin with glyburide (Glucovance)